Biotrin Intl to develop a nucleic acid test (NAT) analyser
DiaSorin has announced that its fully owned Irish subsidiary Biotrin International has signed an agreement with Precision System Science (PSS) of Japan for the development of a nucleic acid test (NAT) analyser.
PSS is a provider of laboratory instruments for nucleic acid extraction and amplification and has several years of experience in the development and production for third parties of automated instruments in the field of molecular diagnostic. According to this agreement, PSS will develop the first-generation analyser to be used in conjunction with a panel of nucleic acid tests in the clinical area of infectious disease which are in development at Biotrin using the LAMP technology.
Biotrin is the DiaSorin centre for the development and manufacture of molecular diagnostics products using the LAMP (loop mediated isothermal amplification) technology, licensed from Eiken Chemical Company. The first panel of applications will be in the field of infectious disease and onco-haematology and will complement DiaSorin’s current extensive Liaison product offering in the field of immunodiagnostics. The commercial launch is expected to happen in the second half of next year.
Phone: 02 9338 4888
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Azure Biosystems Ao Microplate Reader
The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...
Navinci Naveni Plex isPLA multiplex solution
The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...